Detail
LncRNA Name | H19 |
Synonyms | H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2 |
Region | GRCh38_11:1995176-2001470 Sequence |
Ensembl | ENSG00000130600 |
RefSeq | NR_002196 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | thyroid cancer |
ICD-0-3 | C73.9 |
Methods | qPCR, Luciferase reporter assay etc. |
Sample | thyroid cancer tissues, cell lines (TPC-1, NIM, Nthy-ori 3-1 and BCPAP) |
Expression Pattern | up-regulated |
Function Description | Our results suggest that H19 functions as a competitive endogenous RNA (ceRNA) by acting as a sink for miR-17-5p, revealing a potential ceRNA regulatory network involving H19 and miR-17-5p with a role in the modulation of YES1 expression. This mechanism may contribute to a better understanding of thyroid cancer pathogenesis and provide new insights into the treatment of this disease. |
Pubmed ID | 27093644 |
Year | 2016 |
Title | Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer |
External Links |
Links for H19 | GenBank HGNC lncrnadb Noncode |
Links for thyroid cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.